Grace Therapeutics, Inc.
GRCE
$2.14
$0.020.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.22M | -7.79M | -5.98M | -7.82M | -10.31M |
| Total Depreciation and Amortization | 7.00K | 7.00K | 7.00K | 6.00K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.05M | -1.80M | -3.81M | -3.23M | -3.02M |
| Change in Net Operating Assets | -1.12M | 719.00K | -346.00K | -974.00K | 211.00K |
| Cash from Operations | -10.29M | -8.87M | -10.13M | -12.01M | -13.11M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 15.00K | 15.00K |
| Cash from Investing | -- | -- | 0.00 | 15.00K | 15.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.04M | 4.04M | 19.04M | 15.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -327.00K | -1.29M | -1.29M | -1.29M |
| Cash from Financing | 4.04M | 3.71M | 17.75M | 13.71M | 13.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.25M | -5.16M | 7.62M | 1.71M | 611.00K |